BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panels & Respiratory/Sore Throat plus (R/STplus) Panels
Comprehensive Onsite PCR Results in ~15 Minutes.
The BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panels & Respiratory/Sore Throat plus (R/STplus) Panels enable testing for respiratory pathogens from either a nasopharyngeal swab, a throat swab or an anterior nasal swab, providing a flexible respiratory solution across all the continuum of care settings.
Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country. BIOFIRE® SPOTFIRE® R/STplus Panels are not available for sale in the USA.
- Overview
- Panels Menu
- Services & Support
- Specs & Resources
Overview
BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panels & Respiratory/Sore Throat plus (R/STplus) Panels bring PCR diagnostic power closer to patients via a syndromic approach that combines symptom-driven testing for a broad grouping of probable respiratory pathogens into one rapid test, where it matters. With its revolutionary portfolio of versatile, respiratory PCR tests, clinicians can provide patient results in about 15 minutes during their appointments.
- Inform Clinical Decisions: High sensitivity, specificity, and reliability provide results clinicians can trust. Testing for more than flu, RSV, and SARS-CoV-2 with one test provides healthcare professionals with a fuller picture.
- Support Antimicrobial Stewardship: Comprehensive results in a clinically actionable timeframe may support timely diagnosis and more informed decisions on patient management and antimicrobial use1.
- Improve Patient Satisfaction: Using the right test, the first time, to detect multiple pathogens may result in reduced decreased additional visit or return visit, swabbing, and testing, which improve patient comfort, experience, and convenience1.
- Optimize Operations: The simple workflow and quick turnaround time enables rapid and comprehensive answers, which can be communicated to patients during the appointment, potentially reducing the need for callbacks or expensive and slow send-out testing.
References
1. Meltzer A, et al. J Am Coll Emerg Physicians Open. 2024 Oct 23;5(5):e13306.
Services & Support
Make the Most of Your BIOFIRE® SPOTFIRE®
Our goal is to provide you with the best support available while minimizing any disruption to your workflow.
- Best-in-class application and engineering services
- A skilled team dedicated to your success providing global product support, solution training courses, connectivity assistance, and instrument or chemistry related troubleshooting
Specs & Resources
Technical Specifications
| Information | BIOFIRE® SPOTFIRE® Respiratory/Sore Throat plus (R/STplus) Panel | BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel |
|---|---|---|
| Certification: | CE 2797 | FDA Cleared | CLIA Waived |
| Part Number: | 425090 | 423485 |
| Quantity: | 30 Tests | 30 Tests |
| Sample Type: | Nasopharyngeal swab (NPS) or throat swab (TS) in 1 to 3 mL of transport media | Nasopharyngeal swab (NPS) in 3 mL of transport media or throat swab (TS) in 1 mL of transport media |
| Storage Conditions: | All kit components stored at room temperature (15-25 °C) | All kit components stored at room temperature (15-25 °C) |
| Overall Respiratory Performance (NPS specimens): | 98.5% PPA, 99.1% NPA1 | 98.5% PPA, 99.1% NPA2 |
| Overall Sore Throat Performance (TS specimens): | 95.7% PPA, 99.0% NPA1 | 95.9% PPA, 99.0% NPA2 |
| Information | BIOFIRE® SPOTFIRE® Respiratory/Sore Throat plus (R/STplus) Panel Mini | BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini |
|---|---|---|
| Certification: | CE 2797 | FDA Cleared | CLIA Waived |
| Part Number: | 425091 | 424537 |
| Quantity: | 30 Tests | 30 Tests |
| Sample Type: | Anterior Nasal Swab (ANS) and Nasopharyngeal swab (NPS) in 3mL of transport media or Throat Swab (TS) in 1mL of transport media | Anterior Nasal Swab (ANS) and Nasopharyngeal swab (NPS) in 3mL of transport media or Throat Swab (TS) in 1mL of transport media |
| Storage Conditions: | All kit components stored at room temperature (15-25 °C) | All kit components stored at room temperature (15-25 °C) |
| Overall Respiratory Performance (ANS specimens): | 95.6% PPA, 99.1% NPA3 | 95.6% PPA, 99.1% NPA3 |
| Overall Respiratory Performance (NPS specimens): | 98.7% PPA, 98.4% NPA3 | 98.7% PPA, 98.4% NPA4 |
| Overall Sore Throat Performance (TS specimens): | 96% PPA, 98.2% NPA3 | 96.2% PPA, 97.9% NPA4 |
1. Overall performance based on prospective clinical study for the BIOFIRE SPOTFIRE Respiratory/Sore Throat plus (R/STplus) Panel, data on file, BioFire Diagnostics
2. Overall performance based on prospective clinical study for the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel, data on file, BioFire Diagnostics
3. Overall performance based on prospective clinical study for the BIOFIRE SPOTFIRE Respiratory/Sore Throat plus (R/STplus) Panel Mini, data on file, BioFire Diagnostics
4. Overall performance based on prospective clinical study for the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini, data on file, BioFire Diagnostics